Showing posts with label neurotherapy. Show all posts
Showing posts with label neurotherapy. Show all posts

Friday, 9 January 2015

Workshop - Piotr Sobaniec, BCIA-BCN

_______________________________________________________________________________
Effective intervention in patients with autism and ADHD.
Tips and tricks for successful neurotherapy.

Piotr Sobaniec, BCIA-BCN
1-day Workshop


This workshop will assist participants to understand the basic concepts of neurofeedback training protocols and possible cognitive strategies used in the treatment of children with autistic spectrum disorder, ADHD and learning disabilities. It will demonstrate how to improve clinical studies and everyday private practise with neurofeedback.

Presented material is based on our experiences gained from numerous studies conducted at the Department of Pediatrics Neurology and Rehabilitation, Medical University of Bialystok, Poland and Neuromaster Centre in Białystok as well as supervising in various pedagogical and psychological clinics in Poland. Suggested approach consists of a model of cooperation between interdisciplinary therapists and conducting evidence-based therapy with QEEG and ERP analysis. Furthermore, during the workshop 10 points will be discussed that should be considered in planning successful therapy along with another 10 points about what should be avoided.


_______________________________________________________________________________
About Piotr Sobaniec

Piotr Sobaniec is a Ph.D. student at the Medical University of Bialystok, Poland, working for the Department of Pediatrics, Neurology and Rehabilitation. His main clinical work concerns therapy in children with autism and ADHD. Other interests include EEG, QEEG and ERP analysis. In his academic work he is the main lecturer regarding bio and neurofeedback and tutors students pursuing their Masters in neurophysiology.

He first entered the neuro field in the early 2000s, but continuous work and further progress has been ongoing since 2005. With over nine years of experience in the field of medical and biomedical work, he is looking for a challenging post as a clinical therapist that will help enhance his knowledge and hone his skills. He is always interested in new opportunities that will allow him to further his skills and experience in neurotherapy, electroencephalography and biofeedback.

In the 2012 he studied at the ADD Centre, Toronto with Drs. Lynda and Michael Thompson. He fulfilled all requirements and became the first person to be BCIA - Board Certified in Neurofeedback in Poland. Since then, he has become a lecturer conducting workshops and consultations for new neurotherapists. He founded and manages the Neuromaster - Podlaskie Centre of Neurophysiology, Bialystok, Poland.

e-mail: piotr.sobaniec@neuromaster.pl
web: www.neuromaster.pl
www.facebook.com/neuromaster
 

Workshop - Antonio Martins-Mourao, Ph.D.

________________________________________________________________________________
Biomarkers for Anxiety disorders (OCD and PTSD): implications for the design of effective neurotherapy protocols
Antonio Martins-Mourao, Chartered Clin. Psych., PhD
1-day Workshop


What does Anxiety look like in the EEG? This workshop presents an in-depth clinical guide to the identification of neurophysiological subtypes, or EEG-phenotypes, for Anxiety disorders with the focus on Obsessive-Compulsive Disorders (OCD). OCD is an anxiety-related mental health condition affecting 3% of the population. Sufferers experience frequent obsessional thoughts, often resulting in compulsions, impulses or urges. However, symptoms of OCD vary considerably from the ‘mild’ double checking of locks and appliances when leaving home, to the more compulsive hand washing, or the need to keep items symmetrical and object hoarding. You will be introduced to group data and case studies showing neurophysiological differences between subgroups with Anxiety, OCD and healthy controls, and how these differences impact the scores obtained on behavioural questionnaires like the YBOCS (OCD scale) and the MMPI-2-RF (psychopathology scale). We will also discuss how the EEG may predict the best medication for individual cases. Given that nearly half of OCD patients currently fail to respond to drug treatments (Pallanti et al., 2002; Bandelow & Ruther, 2004), this emerging approach represents a clear development from the traditional ‘one-size-fits-all’ classification of behavior solely based on diagnostic manuals such as the DSM-IV. In this 1-day workshop you will learn:

(1) the basics of how to record, deartifact and interpret a QEEG recording,
(2) how to identify the main EEG-phenotypes underlying Anxiety and OCD, and
(3) how to design effective protocols that may predict individual response to neurotherapy and enhanced clinical outcomes within shorter periods.

Intended audience:  psychologists, psychotherapists, physicians, graduate students, neurofeedback practitioners, and other mental health care professionals with an interest in QEEG and neurofeedback integration for treatment planning.

Learning objectives: By the end of this workshop participants will have an understanding of the various neurophysiological and behavioural subtypes found in patients with Anxiety disorders and how this information may support the design personalised neurofeedback protocols for these patients.


________________________________________________________________________________
About Antonio Martins-Mourao, Chartered Clin. Psych., PhD

Antonio Martins-Mourao is a Chartered Clinical Psychologist (BPS) with additional training in Neurophysiology, Neuropsychology and a PhD in Psychology awarded by the University of London. He formerly ran the QEEG & Brain Research Lab (Open University, UK), which pioneered the use of psychological testing, Quantitative Electroencephalography QEEG, Event-related ERP and Neurofeedback techniques to investigate psychological and neurophysiological subtypes in patients with Anxiety Disorders (OCD and PTSD). Antonio is clinical director at London Scientific Neurotherapy (Harley St., London). He is also a member of the British Neuroscience Association BNA, the Society for Applied Neuroscience SAN and a member of the board for the International Society for Neurofeedback Research - Research Foundation ISNR-RF. His other interests include theology, comparative religion and screenwriting.

Saturday, 15 November 2014

Workshop - Paul G. Swingle, Ph.D.

__________________________________________________________________________________
Basics of the ClinicalQ Database and Braindriving
Paul G. Swingle, Ph.D.
1-day Workshop

Neurotherapy is rapidly evolving into a primary care option for many disorders. Problems with mood, anxiety, sleep quality, learning, cognitive processing, pain, addictions, anger management, and age related memory are all amenable to rapid assessment and treatment. The assessment procedures are simple and straight forward involving assessment of a limited number of brain sites. Treatment options other than neurofeedback have been developed to markedly accelerate neurotherapy. These complementary techniques markedly facilitate neurotherapy as a viable primary care alternative to dangerous and often ineffective pharmaceuticals.

The workshop starts with the precise ClinicalQ assessment procedure that determines treatment strategies. Emphasis is on Braindriving treatment procedures including review of major unconditioned stimuli required for treatment. Other treatment options including neurofeedback, AVS, CES, energy psychology methods, craniosacral manipulations, harmonic sounds, electrostimulation, and behavior therapies appropriate for a wide range of disorders are presented. Practitioners will be able to immediately apply these efficient techniques. Conditions that require full QEEG and normative data base procedures will be identified as will conditions in which the more aggressive treatments are contraindicated.

________________________________________________________________________________
Neurotherapeutic Treatment of Depression
Paul D. Swingle, Ph.D.
1-day Workshop

Neurotherapy has been shown to be very efficient for treatment of the many forms of “depression.” Most important, EEG assessments based on clinical normed data bases precisely identifies the various forms of this condition and critically identifies those conditions that are mistakenly treated as depression. Severe anxiety, for example, has a very different neurological profile from depression but clients often report “depression” because their lives are in shambles as a result of disabling anxiety.

Many clinical clients also have histories of emotional trauma and many also present for treatment as a result of on-going or recent traumatic stress. The ClinicalQ assessment helps identify those conditions that may be more efficaciously treated with therapies other than those neurologically based.

The ClinicalQ EEG intake assessment is remarkably accurate for identifying clients with unresolved post-traumatic stress, endogenous predispositions to depression or anxiety as well as other conditions that mimic “depression.” Combining the EEG markers for “trauma” with endogenous neurological conditions that affect manifestation of depression provide guides for neurotherapeutic treatment.

The workshop reviews the diagnostic procedures for identifying the neurological conditions associated with the client’s symptoms as well as identifying the neurological “foot-print” for exposure to severe emotional stressors that have not been resolved.

Neurotherapy is not a stand-alone treatment modality. The second portion of the workshop, therefore, focuses on the combination of neurotherapy, particularly braindriving technology, with other therapeutic procedures for very effective treatment of the wide array of clinical conditions that are the basis for clients seeking treatment for “depression.”


 ________________________________________________________________________________
About Dr. Paul G. Swingle

Dr. Swingle is a Fellow of the Canadian Psychological Association and a former Lecturer in Psychiatry at Harvard Medical School. Professor Swingle formerly held the posts of Chairman of the Faculty of Child Psychology and Clinical Supervisor at the University of Ottawa. He has taught at McGill University, Dalhousie University and McMaster University. He is a Registered Psychologist in British Columbia and is (BCIA) Certified in Biofeedback and Neurotherapy. Since 1997 he has been in private practice in Vancouver, British Columbia. His most recent book Biofeedback for the Brain (2008) was published by Rutgers University Press.

_________________________________________________________________________________
About the ClinicalQ nd BrainDryvr Software Suite